Roche aims to be an effective and valued healthcare partner. This is how we see ourselves and how we strive to be viewed by NHS managers and healthcare professionals, government bodies and patient groups alike.
 
As one of the major pharmaceutical and diagnostic companies in the UK, Roche develops and provides an innovative range of products and services that help healthcare professionals improve the health and well-being of the UK population.

Supporting our medicines are a range of innovative services that add value for patients, clinicians, health service commissioners and NHS managers. We support the aims of government in enabling more services to be delivered in the community setting, such as GP surgeries; improved patient choice; and supporting early disease intervention to prevent long term suffering. In particular, many of our innovative oral treatments themselves enable the shift from hospital to community based care in some cases by replacing intravenous drug treatments, where there is equivalent efficacy, whilst at the same time alleviating capacity pressures in hospitals and freeing up the time of nurses and pharmacists.

For complete information about how we work, you can download our PDF leaflet "Roche a Healthcare Partner with the NHS"

Patient organisations to which Roche provides financial support & types of support received:

Core funding for the human and physical resources needed to run the organisation and/or activity that the patient group decides to carry out, with no Roche involvement
Funding of specific project, educational or collaborative, to which both parties will contribute
Funding a third party agency to provide support for the patient group in its educational activities

African HIV Policy Network
Core funding

Arthritis and Muscoskeletal Alliance
Core funding

Arthritis Care
Core funding

Beating Bowel Cancer
Funding of specific project

Bowel Cancer UK
Funding of specific project, Funding a third party agency

Breakthrough Breast Cancer
Funding of specific project

Cancer Campaigning Group
Funding of specific project

CancerBACKUP
Funding of specific project

CLL Support Association
Core funding, Funding of specific project

Hepatitis C trust
Funding of specific project, Funding a third party agency

HIV I-Base
Core funding

HIV Scotland
Core funding

Kent Kidney Patient Association
Funding of specific project

Kidney Research UK
Core funding, Funding a third party agency

Leukaemia Care
Core funding, Funding of specific project
Funding a third party agency

Long term Conditions Alliance
Core funding

Mens Health Forum
Funding of specific project

NAM Publications Ltd
Core funding

National Aids Trust
Core funding

Ovacome
Core funding, Funding of specific project

Osteoporosis Dorset
Funding of specific project

Pamela Northcott Fund
Core funding

Plus VE
Funding of specific project

Rarer Cancers Forum
Funding of specific project

Rheumatology Futures Group
Core funding

The Hepatitis C Trust
Funding of specific project, Funding a third party agency

The Kings Foundation
Core funding

The Lymphoma Association
Funding of specific project

The National Kidney Federation
Funding of specific project, Funding a third party agency

The National Rheumatoid Arthritis Society
Core funding

The Roy Castle Lung Cancer Foundation
Funding of specific project, Funding a third party agency

The UK Lung Cancer Coalition - Core funding

The Willow Foundation - Funding of specific project

Contact Information:
For more information email welwyn.corporate_affairs@roche.com